Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Green Growth Brands Fourth Quarter Revenue Increases 29% Quarter-Over-Quarter to $7.2 Million

      Green Growth Brands (CNW Group/Green Growth Brands)

      News provided by

      Green Growth Brands

      Oct 23, 2019, 18:18 ET

      Share this article

      Share this article


      GGB reports total revenue of $15.7 million in its first partial year of operations

      COLUMBUS, OH, Oct. 23, 2019 /PRNewswire/ - Green Growth Brands Inc. (GGB or the Company) (CSE: GGB) (OTCQB: GGBXF) today reported its results for the fourth quarter and full year ended June 30, 2019. The Company reported total revenue for fiscal 2019 of $15.7 million. For the three month period ended June 30, 2019, the Company reported a 29% quarter-over-quarter increase in revenue to $7.2 million.

      "In a short-time we have built a pathway to open up to 47 dispensaries in three key states and established the first, best and only vertical CBD distribution network in the country," said Peter Horvath, CEO of Green Growth Brands. "This foundation leverages our strengths of creating brands consumers love, building innovative product assortments and operating and growing retail at scale, quarter after quarter.

      "As we look ahead to fiscal 2020, our focus will shift from foundation building to operating and executing, which we expect to result in a steep sequential growth in both our CBD and MSO businesses."

      To read more of Horvath's thoughts on the growth and trajectory of the business, please read the Letter to Shareholders.

      GGB will host a conference call and audio webcast with Chief Executive Officer, Peter Horvath, and Chief Financial Officer, Brian Logan, at 8:30 AM EDT on Thursday, October 24, 2019.

      Fourth Quarter & Full Year Fiscal 2019 Highlights

      • Total revenue for fiscal 2019 was $15.7 million, which reflects seven and a half months of MSO revenue since the reverse takeover in November 2018 and the launch of the CBD business in February 2019.

      • Total revenue for the quarter, including both MSO and CBD operations, was $7.2 million, a sequential increase of 29% over the prior quarter.

      • MSO revenue for the quarter, which primarily consists of one dispensary in Las Vegas, The+Source, was $5.5 million, a sequential increase of 7% over the prior quarter.

      • The+Source continues to generate annualized revenue of nearly $15,000 per selling square foot, one of the highest reported figures in the industry and in retail overall.1

      • CBD revenue for the quarter was $1.7 million, a sequential increase of 271% over the prior quarter. Q1 fiscal 2020 CBD revenue is expected to grow by approximately 200%.

      • As of the June 30, 2019, the Company operated 58 CBD shops, including 52 that opened during the quarter.

      • The Executive team was expanded during the quarter with the addition of Jann Parish as Chief Marketing Officer. Parish brings significant branding, marketing and consumer expertise to the Company.

      • During the full year, the Company entered into CBD wholesale partnerships with Abercrombie & Fitch for 161 stores, DSW for a total of 155 stores and white labeling American Eagle's MOOD for 500 of their stores.

      ______________
      1 eMarketer Retail, "Ecommerce trends and store sales for top retailers"

      Subsequent Events

      • In August, the Company completed a C$50 million bought deal and the founders posted a backstop commitment of up to C$102 million.

      • In August, the Company announced the completion of the acquisition of Florida-based Spring Oaks, granting The Company the ability to open and operate up to 35 licenses in Florida.

      • In August, the Company completed the acquisition of Henderson Organic Remedies, LLC (The+Source Henderson), the sister location of The+Source Las Vegas.

      • The Company is currently operating over 160 CBD shops and expects to reach over 200 by the holiday shopping season this year.

      Fourth Quarter & Full Year Fiscal 2019 Financial Statements

      The following tables contain financial information for the periods indicated. For full financial information, notes, and management commentary please refer to the MD&A and Financial Statements posted on Green Growth Brands' Investor Relations site and SEDAR. All financial information is provided in United States dollars, unless otherwise indicated. "Adjusted EBITDA" is equal to net income (loss) before interest, taxes and depreciation and amortization, plus fair value adjustments on sale of inventory and on growth of biological assets, share-based compensation and payments, loss (gain) on equity investments, loss (gain) on foreign exchange, loss (gain) on short-term investments, transaction costs, listing fees and certain one-time non-operating expenses, as determined by management. Management believes this measure provides useful information as it is a commonly used measure in the capital markets and as it is a close proxy for repeatable cash generated by (used for) operations.

      Consolidated Statements of Financial Position

      As at June 30, 2019 and June 30, 2018

      (Expressed in United States dollars)





      June 30, 2019

      June 30, 2018





      Assets



      Current Assets




      Cash

      $

      10,256,008

      $

      4,688,311


      Short term investments

      -

      -


      Receivables

      580,529

      -


      Prepaid expenses

      5,142,618

      -


      Inventories

      10,244,804

      -


      Biological assets

      1,352,097

      -


      Notes receivable

      47,739

      -


      Other receivables

      3,006,760

      18,269


      Deferred lease charges

      727,518

      -



      31,358,073

      4,706,580






      Property and equipment, net

      18,761,723

      -


      Deposits and other assets

      2,880,186

      -


      Deferred lease charges

      2,606,940

      -


      Notes receivable

      17,999,224

      -


      Intangible assets

      39,925,984

      -


      Goodwill

      36,253,417

      -

       Total assets

      $

      149,785,547

      $

      4,706,580





      Liabilities



      Current Liabilities




      Accounts payable and accrued liabilities

      16,328,784

      316,768


      Taxes payable

      282,593

      -


      Due to related parties

      317,535

      -


      Notes payable

      45,762,540

      -


      Embedded derivative liability

      1,496,214

      -


      Convertible Debenture

      41,623,041

      -



      105,810,707

      316,768






      Deferred tax liability

      1,437,324

      -





      Shareholders' Equity




      Share capital

      119,881,374

      7,016,421


      Reserve for warrants

      9,054,624

      -


      Reserve for share based compensation

      3,147,110

      -


      Accumulated deficit

      (92,453,943)

      (2,626,609)


      Accumulated other comprehensive income

      148,286

      -

      Total equity attributable to shareholders of Green Growth Brands Inc.

      39,777,451

      4,389,812

      Non-controlling interest

      2,760,065

      -

      Total equity

      42,537,516

      4,389,812

      Total liabilities and equity

      $

      149,785,547

      $

      4,706,580

      Consolidated Statements of Loss and Comprehensive Loss

      For the three months ended June 30 2019 and June 30, 2018


      (Expressed in United States dollars)


      June 30, 2019

      June 30, 2018

      Sales



      Revenue

      7,174,674

      -

      Cost of goods sold

      7,908,224

      -

      Gross profit before fair value adjustments

      (733,550)

      -

      Fair value change in biological assets included in inventory sold and other charges

      (863,649)

      -

      Unrealized gain on changes in fair value of biological assets

      706,200

      -




      Gross profit

      (576,101)

      -




      Operating Expenses



      General and administrative

      5,536,395

      1,146,474

      Legal and professional fees

      5,198,484

      788,716

      Sales and marketing

      5,540,252

      -

      Stock based compensation

      2,136,271

      -

      Depreciation and amortization

      609,765

      -

      Other income

      1,027,440

      -


      20,048,607

      1,935,190




      Other expenses (income)



      Loss on equity investments

      -

      -

      Gain in fair value of derivative liability

      (2,739,549)

      -

      Interest expense

      1,266,595

      1,113

      Accretion on convertible debenture

      466,264

      -

      Foreign exchange loss

      1,070,883

      96,967

      Realized gain on short term investments

      6,617,587

      -

      Transaction costs

      3,608,655

      -

      Net loss before listing fees and income taxes

      (30,915,143)

      (2,033,270)

      Listing fees

      68,055

      -

      Net loss after listing fees

      (30,983,198)

      (2,033,270)

      Income taxes

      538,704

      -

      Net loss after income taxes

      (31,521,902)

      (2,033,270)

      Less: Non-controlling interest

      50,799

      -

      Net Loss attributable to owners of the parent

      (31,471,103)

      (2,033,270)




      Net loss per Common Share attributable to the parent



      Basic and Diluted

      (0.19)

      (0.04)




      Weighted average common shares

      165,637,384

      48,772,788




      Other comprehensive loss



      Exchange gain on translating foreign operations

      -

      -

      Comprehensive loss

      $

      (31,471,103)

      $

      (2,033,270)

      Adjusted EBITDA



      (Expressed in United States dollars)





      June 30, 2019

      June 30, 2018






      Net loss after listing fees before income taxes

      $

      (30,983,198)

      $

      (2,033,270)






      Fair value adjustment on sale of inventory

      (863,649)

      -


      Fair value adjustment on biological assets

      706,200

      -


      Stock based compensation

      2,136,271

      -


      Depreciation and amortization

      609,765

      -


      Shares issued for services

      1,573,079

      -


      Pre-opening expenses

      812,957

      -


      Non-operating expenses

      10,290,435

      98,080


      Listing fees

      68,055

      -



      15,333,113

      98,080


      Adjusted EBITDA

      $

      (15,650,085)

      $

      (1,935,190)

      Consolidated Statements of Loss and Comprehensive Loss

      For the year ended June 30 2019 and for the period from February 14, 2018 to June 30, 2018


      (Expressed in United States dollars)



      June 30, 2019

      June 30, 2018




      Sales



      Revenue

      $

      15,729,803

      $

      -

      Cost of goods sold

      16,404,133

      -

      Gross profit before fair value adjustments

      (674,330)

      -

      Fair value change in biological assets included in inventory sold and other charges

      662,212

      -

      Unrealized gain on changes in fair value of biological assets

      (1,012,549)

      -

      Gross profit

      (323,993)

      -




      Operating Expenses



      General and administrative

      20,751,480

      1,364,719

      Legal and professional fees

      15,423,098

      1,163,810

      Sales and marketing

      8,632,651

      -

      Stock based compensation

      3,839,254

      -

      Depreciation and amortization

      1,191,682

      -

      Other income

      (39,581)

      -


      49,798,584

      2,528,529


      (50,122,577)

      (2,528,529)

      Other expenses (income)



      Loss on equity investments

      671,579

      -

      Gain in fair value of derivative liability

      (2,739,549)

      -

      Interest expense

      3,509,419

      1,113

      Accretion on convertible debenture

      466,264

      -

      Foreign exchange loss

      1,419,220

      96,967

      Realized gain on short term investments

      (4,347,339)

      -

      Transaction costs

      13,260,093

      -

      Net loss before listing fees and income taxes

      (62,362,264)

      (2,626,609)

      Listing fees

      767,245

      -

      Net loss after listing fees

      (63,129,509)

      (2,626,609)

       Income taxes

      1,202,300

      -

      Net loss after income taxes

      $

      (64,331,809)

      $

      (2,626,609)

      Less: Non-controlling interest

      77,435

      -

      Net Loss attributable to owners of the parent

      $

      (64,254,374)

      $

      (2,626,609)




      Net loss per Common Share attributable to the parent



      Basic and Diluted

      $

      (0.40)

      $

      (0.05)




      Weighted average common shares

      161,188,156

      54,794,120




      Other comprehensive loss



      Exchange gain on translating foreign operations

      148,286

      -

      Comprehensive loss

      $

      (64,106,088)

      $

      (2,626,609)

      Consolidated Statement of Cashflow

      For the year ended June 30, 2019, and for the period from February 14, 2018 to June 30, 2018

      (Expressed in United States dollars)





      June 30, 2019

      June 30, 2018

      Cashflow from Operating Activities




      Net loss for the period

      $

      (64,331,809)

      $

      (2,626,609)

      Adjustments for:




      Stock based compensation

      3,839,254

      -


      Shares and warrants issued for services

      6,701,445

      -


      Depreciation and amortization

      1,191,683

      -


      Deferred lease charges

      303,132

      -


      Deferred tax expense

      473,244

      -


      Accretion expense

      466,264

      -


      Loss on equity investment

      671,579

      -


      Realized gain on short term investment

      (4,347,339)

      -


      Transaction costs

      6,617,110

      -


      Fair value of embedded derivative liability

      (2,739,549)

      -


      Net fair value adjustment on growth of biological assets

      (350,337)

      -


      Foreign exchange on translation

      1,402,691

      -

      Changes in non-cash working capital balances




      Receivables

      (243,764)

      -


      Prepaid expenses

      (5,142,618)

      -


      Other receivables

      (761,169)

      (18,269)


      Inventories

      (8,179,761)

      -


      Biological assets

      (143,082)

      -


      Accounts payable and accrued liabilities

      8,809,632

      316,768


      Income taxes payable

      282,593

      -



      (55,480,801)

      (2,328,110)

      Cashflow from Investing Activities




      Purchase of property and equipment

      (9,802,924)

      -


      Purchase of software

      (1,037,729)

      -


      Acquisition of businesses, net of cash acquired

      (44,437,592)

      -


      Purchase of short term investments

      (16,945,040)

      -


      Net proceeds from sale of short term investments

      21,347,468

      -


      Proceeds from sale of equity investment

      73,381

      -


      Advance on Henderson Organic Remedies LLC acquisition

      (15,485,000)

      -


      Advances on acquisitions

      (3,650,000)

      -


      Purchase of equity investment

      (300,000)

      -



      (70,237,436)

      -

      Cashflow from Financing Activities




      Shares issued on warrants and options exercised

      43,514,989

      -


      Repayment of notes

      (6,485,030)

      -


      Proceeds from convertible debentures, net of issuance costs

      106,196,985

      -


      Proceeds from private placement share capital issued

      25,747,713

      7,016,421


      Redemption of common shares

      (37,170,000)

      -



      131,804,657

      7,016,421

      Effect of exchange rates on cash

      (518,723)

      -

      Increase in cash

      5,567,697

      4,688,311





      Cash, beginning of period

      4,688,311

      -





      Cash, end of period

      $

      10,256,008

      $

      4,688,311





      Supplemental disclosure of cash flow information




      Interest paid

      2,061,511

      -


      Income taxes paid

      446,462

      -

      Other non-cash investing and financing activities




      Capital assets not yet paid for

      5,773,117



      Redemption of common shares by issuance of promissory note

      28,992,600

      -

      Segmented statement of operations for the three months ended June 30, 2019 and June 30, 2018


      (Expressed in United States dollars)



      MSO

      CBD

      Head office

      Allocations

      Total



      2019

      2018

      2019

      2018

      2019

      2018

      2019

      2018

      2019

      2018













      Sales












      Revenue

      $

      5,461,941

      $

      -

      $

      1,712,733

      $

      -

      $

      -

      $

      -

      $

      -

      $

      -

      $

      7,174,674

      $

      -


      Cost of goods sold

      3,976,025

      -

      2,513,376

      -

      -

      -

      1,418,823

      -

      7,908,224

      -

      Gross profit before fair value adjustments

      1,485,916

      -

      (800,643)

      -

      -

      -

      (1,418,823)

      -

      (733,550)

      -


      Fair value change in biological assets included in inventory
      sold and other charges

      (863,649)

      -

      -

      -

      -

      -

      -

      -

      (863,649)

      -


      Unrealized gain on changes in fair value of biological assets

      706,200

      -

      -

      -

      -

      -

      -

      -

      706,200

      -

      Gross profit

      1,643,365

      -

      (800,643)

      -

      -

      -

      (1,418,823)

      -

      (576,101)

      -













      Operating Expenses












      General and administration

      -

      -

      -

      -

      6,521,008

      1,146,474

      (984,613)

      -

      5,536,395

      1,146,474


      Legal and professional fees

      -

      -

      -

      -

      5,640,914

      788,716

      (442,430)

      -

      5,198,484

      788,716


      Sales and marketing

      394,488

      -

      4,986,676

      -

      148,277

      -

      10,811

      -

      5,540,252

      -


      Stock based compensation

      -

      -

      -

      -

      2,136,271

      -

      -

      -

      2,136,271

      -


      Depreciation and amortization

      -

      -

      155,955

      -

      456,401

      -

      (2,591)

      -

      609,765

      -


      Other income

      (15,932)

      -

      -

      -

      1,043,372

      -

      -

      -

      1,027,440

      -



      378,556

      -

      5,142,631

      -

      15,946,243

      1,935,190

      (1,418,823)

      -

      20,048,607

      1,935,190



      1,264,809

      -

      (5,943,274)

      -

      (15,946,243)

      (1,935,190)

      -

      -

      (20,624,708)

      (1,935,190)

      Non-operating expenses












      Loss on equity investment in Xanthic Beverages USA, LLC

      -

      -

      -

      -

      -

      -

      -

      -

      -


      Gain in fair value of derivative liability

      -

      -

      -

      -

      (2,739,549)

      -

      -

      -

      (2,739,549)

      -


      Interest expense

      -

      -

      -

      -

      1,266,595

      1,113

      -

      -

      1,266,595

      1,113


      Accretion expense

      -

      -

      -

      -

      466,264

      -

      -

      -

      466,264

      -


      Foreign exchange loss (income)

      -

      -

      -

      -

      1,070,883

      96,967

      -

      -

      1,070,883

      96,967


      Unrealized gain on marketable securities

      -

      -

      -

      -

      6,617,587

      -

      -

      -

      6,617,587

      -


      Transaction costs

      -

      -

      -

      -

      3,608,655

      -

      -

      -

      3,608,655

      -

      Net income (loss) before listing fees and income taxes

      1,264,809

      -

      (5,943,274)

      -

      (26,236,678)

      (2,033,270)

      -

      -

      (30,915,143)

      (2,033,270)


      Listing fees

      -

      -

      -

      -

      68,055

      -

      -

      -

      68,055

      -

      Net income (loss) after listing fees

      1,264,809

      -

      (5,943,274)

      -

      (26,304,733)

      (2,033,270)

      -

      -

      (30,983,198)

      (2,033,270)


       Income taxes

      538,704

      -

      -

      -

      -

      -

      -

      -

      538,704

      -

      Net Income (loss) after income taxes

      $

      726,105

      $

      -

      $

      (5,943,274)

      $

      -

      $

      (26,304,733)

      $

      (2,033,270)

      $

      -

      $

      -

      $

      (31,521,902)

      $

      2,033,270)













      Net income (loss) and comprehensive loss attributable to:












      Owners of the parent

      776,904

      -

      (5,943,274)

      -

      (26,304,733)

      (2,033,270)

      -

      -

      (31,471,103)

      (2,033,270)


      Non-controlling interest

      50,799

      -

      -

      -

      -

      -

      -

      -

      50,799

      -



      726,105

      -

      (5,943,274)

      -

      (26,304,733)

      (2,033,270)

      -

      -

      (31,521,902)

      (2,033,270)

      Segmented statement of operations for the year ended June 30, 2019


      (Expressed in United States dollars)



      MSO

      CBD

      Head office

      Allocations

      Total



      2019

      2018

      2019

      2018

      2019

      2018

      2019

      2018

      2019

      2018













      Sales












      Revenue

      $

      13,490,190

      $

      -

      $

      2,239,613

      $

      -

      $

      -

      $

      -

      $

      -

      $

      -

      $

      15,729,803

      $

      -


      Cost of goods sold

      8,844,293

      -

      3,599,882

      -

      -

      -

      3,959,958

      -

      16,404,133

      -

      Gross profit before fair value adjustments

      4,645,897

      -

      (1,360,269)

      -

      -

      -

      (3,959,958)

      -

      (674,330)

      -


      Fair value change in biological assets included in inventory
      sold and other charges

      662,212

      -

      -

      -

      -

      -

      -

      -

      662,212

      -


      Unrealized gain on changes in fair value of biological assets

      (1,012,549)

      -

      -

      -

      -

      -

      -

      -

      (1,012,549)

      -

      Gross profit

      4,996,234

      -

      (1,360,269)

      -

      -

      -

      (3,959,958)

      -

      (323,993)

      -













      Operating Expenses












      General and administration

      -

      -

      -

      -

      22,791,162

      1,364,719

      (2,039,682)

      -

      20,751,480

      1,364,719


      Legal and professional fees

      -

      -

      -

      -

      17,337,691

      1,163,810

      (1,914,593)

      -

      15,423,098

      1,163,810


      Consulting fees

      -


      -


      -




      -

      -


      Sales and marketing

      2,104,497

      -

      5,624,291

      -

      903,863

      -

      -

      -

      8,632,651

      -


      Stock based compensation

      -

      -

      -

      -

      3,839,254

      -

      -

      -

      3,839,254

      -


      Depreciation and amortization

      68,500

      -

      178,938

      -

      949,927

      -

      (5,683)

      -

      1,191,682

      -


      Other income

      (39,060)

      -

      -

      -

      (521)

      -

      -

      -

      (39,581)

      -



      2,133,937

      -

      5,803,229

      -

      45,821,376

      2,528,529

      (3,959,958)

      -

      49,798,584

      2,528,529



      2,862,297

      -

      (7,163,498)

      -

      (45,821,376)

      (2,528,529)

      -

      -

      (50,122,577)

      (2,528,529)

      Non-operating expenses












      Loss on equity investment in Xanthic Beverages USA, LLC

      -

      -

      -

      -

      671,579

      -

      -

      -

      671,579

      -


      Gain in fair value of derivative liability

      -

      -

      -

      -

      (2,739,549)

      -

      -

      -

      (2,739,549)

      -


      Interest expense

      -

      -

      -

      -

      3,509,419

      1,113

      -

      -

      3,509,419

      1,113


      Accretion expense

      -

      -

      -

      -

      466,264

      -

      -

      -

      466,264

      -


      Foreign exchange loss (income)

      -

      -

      -

      -

      1,419,220

      96,967

      -

      -

      1,419,220

      96,967


      Unrealized gain on marketable securities

      -

      -

      -

      -

      (4,347,339)

      -

      -

      -

      (4,347,339)

      -


      Transaction costs

      -

      -

      -

      -

      13,260,093

      -

      -

      -

      13,260,093

      -

      Net income (loss) before listing fees and income taxes

      2,862,297

      -

      (7,163,498)

      -

      (58,061,063)

      (2,626,609)

      -

      -

      (62,362,264)

      (2,626,609)


      Listing fees

      -

      -

      -

      -

      767,245

      -

      -

      -

      767,245

      -

      Net income (loss) after listing fees

      2,862,297

      -

      (7,163,498)

      -

      (58,828,308)

      (2,626,609)

      -

      -

      (63,129,509)

      (2,626,609)


       Income taxes

      1,202,300

      -

      -

      -

      -

      -

      -

      -

      1,202,300

      -

      Net income (loss) after income taxes

      $

      1,659,997

      $

      -

      $

      (7,163,498)

      $

      -

      $

      (58,828,308)

      $

      (2,626,609)

      $

      -

      $

      -

      $

      (64,331,809)

      $

      (2,626,609)













      Net income (loss) and comprehensive loss attributable to:












      Owners of the parent

      1,737,432

      -

      (7,163,498)

      -

      (58,828,308)

      (2,626,609)

      -

      -

      (64,254,374)

      (2,626,609)


      Non-controlling interest

      77,435

      -

      -

      -

      -

      -

      -

      -

      77,435

      -



      1,659,997

      -

      (7,163,498)

      -

      (58,828,308)

      (2,626,609)

      -

      -

      (64,331,809)

      (2,626,609)













      Supplemental segmented information












      Assets

      107,923,000

      -

      29,556,255

      -

      12,306,292

      4,706,580

      -

      -

      149,785,547

      4,706,580


      Liabilities

      18,449,277

      -

      7,307,803

      -

      81,490,951

      316,768

      -

      -

      107,248,031

      316,768

      Conference Call Information:

      Conference ID: 66844833

      Local Toronto Dial-in Number: (+1) 416 764 8609

      Local Vancouver Dial-in Number: (+1) 778 383 7417

      North American Toll-Free Number:(+1) 888 390 0605

      The call and replay archive will be accessible on Green Growth Brands' Investor Relations website.

      About Green Growth Brands Inc.
      Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company's brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The Company also has a licensing agreement with the Greg Norman™ Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S its CBD presence at ShopSeventhSense.com, in malls across the country, at DSW and Abercrombie & Fitch stores—and that's just the beginning. Learn more about the vision at  GreenGrowthBrands.com.

      Cautionary Statements:

      Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "intend", "forecast" and similar expressions.   Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Company to implement its business strategies; competition; currency and interest rate fluctuations and other risks, including those factors described under the heading "Risks Factors" in the Company's Annual Information Form dated November 26, 2018 which is available on the Company's issuer profile on SEDAR.

      Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release, including, but not limited to, the Company's ability to execute on its growth strategy, the Company's plan to open new dispensaries in the remainder of the calendar year, the Company's vision to become a multi-state operator with retail stores exceeding certain financial thresholds is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

      This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.

      The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

      SOURCE Green Growth Brands

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.